|
|
.
See Category: Diseases of the respiratory system
See Header: Moderate persistent asthma
ICD-10 (CM) Code and Descriptor
|
J45.40 |
Moderate persistent asthma, uncomplicated
|
J4540 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 37.82%
|
16.98%
|
11.34%
|
8.80%
|
6.53%
|
4.99%
|
3.68%
|
2.69%
|
1.93%
|
1.48%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for J45.40*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
J2357
|
OMALIZUMAB INJECTION |
22,802
|
986,149
|
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
21,336
|
21,386
|
|
96372
|
THER/PROPH/DIAG INJ SC/IM |
21,006
|
29,020
|
|
94729
|
CO/MEMBANE DIFFUSE CAPACITY |
5,315
|
5,316
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
5,218
|
5,233
|
|
94060
|
EVALUATION OF WHEEZING |
5,086
|
5,087
|
|
G0467
|
FQHC VISIT, ESTAB PT |
4,248
|
4,248
|
|
G0239
|
OTH RESP PROC, GROUP |
4,160
|
4,446
|
|
94726
|
PULM FUNCT TST PLETHYSMOGRAP |
3,890
|
3,891
|
|
99214
|
OFFICE O/P EST MOD 30 MIN |
3,868
|
3,869
|
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
3,821
|
3,835
|
|
J2182
|
INJECTION, MEPOLIZUMAB, 1MG |
3,467
|
349,050
|
|
71046
|
X-RAY EXAM CHEST 2 VIEWS |
3,389
|
3,389
|
|
99213
|
OFFICE O/P EST LOW 20 MIN |
3,385
|
3,385
|
|
94010
|
BREATHING CAPACITY TEST |
3,256
|
3,256
|
|
86003
|
ALLG SPEC IGE CRUDE XTRC EA |
3,008
|
34,210
|
|
82785
|
ASSAY OF IGE |
2,622
|
2,642
|
|
96401
|
CHEMO ANTI-NEOPL SQ/IM |
2,517
|
2,980
|
|
80053
|
COMPREHEN METABOLIC PANEL |
1,973
|
1,973
|
|
G2025
|
DIS SITE TELE SVCS RHC/FQHC |
1,628
|
1,628
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
J45.40 related to the following DRG Codes:
202-203
|
